148 related articles for article (PubMed ID: 32437951)
1. Outcome benefit of arterial duplex stent imaging after superficial femoral artery stent implantation.
Draxler MS; Al-Adas Z; Abbas D; Kavousi Y; Kabbani LS; Lin JC; Weaver MR; Shepard AD; Nypaver TJ
J Vasc Surg; 2021 Jan; 73(1):179-188. PubMed ID: 32437951
[TBL] [Abstract][Full Text] [Related]
2. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting.
Hayes DJ; Dougherty MJ; Calligaro KD
Ann Vasc Surg; 2011 May; 25(4):559.e19-23. PubMed ID: 21549939
[TBL] [Abstract][Full Text] [Related]
3. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.
Schneider JR; Verta MJ; Alonzo MJ; Hahn D; Patel NH; Kim S
Vasc Endovascular Surg; 2011 Jul; 45(5):391-7. PubMed ID: 21669863
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
5. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent.
Lenti M; Cieri E; De Rango P; Pozzilli P; Coscarella C; Bertoglio C; Troiani R; Cao P
J Vasc Surg; 2007 Jan; 45(1):32-9. PubMed ID: 17210380
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
Ohki T; Kichikawa K; Yokoi H; Iida O; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2021 Dec; 74(6):1958-1967.e2. PubMed ID: 34182032
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of open and endovascular revascularization of superficial femoral artery occlusive disease.
Scali ST; Rzucidlo EM; Bjerke AA; Stone DH; Walsh DB; Goodney PP; Chang CK; Powell RJ
J Vasc Surg; 2011 Sep; 54(3):714-21. PubMed ID: 21620611
[TBL] [Abstract][Full Text] [Related]
9. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
10. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial.
Nasser F; Kambara A; Abath C; Cavalcanti D; Barros I; Pires N; Rivera M; Neser A; Ingrund J; Burihan M; Silveira P; Galego G; Bortoluzzi C; Franklin R; Bosiers M; Deloose K; Razuk A; Caffaro R; Karakhanian WK; Park J; Lopes C; Pinto D; Bez L; Lopes R; Mourão A; Kleinsorge G
J Cardiovasc Surg (Torino); 2017 Jun; 58(3):409-415. PubMed ID: 25731858
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study.
Werner M; Micari A; Cioppa A; Vadalà G; Schmidt A; Sievert H; Rubino P; Angelini A; Scheinert D; Biamino G
JACC Cardiovasc Interv; 2014 Mar; 7(3):305-12. PubMed ID: 24529932
[TBL] [Abstract][Full Text] [Related]
13. Stent fractures after superficial femoral artery stenting: risk factors and impact on patency.
Lin Y; Tang X; Fu W; Kovach R; George JC; Guo D
J Endovasc Ther; 2015 Jun; 22(3):319-26. PubMed ID: 25862365
[TBL] [Abstract][Full Text] [Related]
14. Performance of ePTFE-covered endograft in patients with occlusive disease of the superficial femoral artery: a three-year clinical follow-up study.
Fritschy WM; Kruse RR; Frakking TG; Van Geloven AA; Blomme AM
J Cardiovasc Surg (Torino); 2010 Dec; 51(6):783-90. PubMed ID: 21124274
[TBL] [Abstract][Full Text] [Related]
15. Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery.
Baril DT; Rhee RY; Kim J; Makaroun MS; Chaer RA; Marone LK
J Vasc Surg; 2009 Jan; 49(1):133-8; discussion 139. PubMed ID: 19174252
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Self-Expandable Nitinol Stent Implantation With Intraluminal Angioplasty to Treat Chronic Total Occlusion in the Superficial Femoral Artery (TransAtlantic Inter-Society Consensus Type D Lesions).
Matsumi J; Ochiai T; Tobita K; Shishido K; Sugitatsu K; Mizuno S; Yamanaka F; Murakami M; Tanaka Y; Takahashi S; Akasaka T; Saito S
J Invasive Cardiol; 2016 Feb; 28(2):58-64. PubMed ID: 26841438
[TBL] [Abstract][Full Text] [Related]
17. Hybrid Revascularization Combining Iliofemoral Endarterectomy and Iliac Stent Grafting for TransAtlantic Inter-Society Consensus C and D Aortoiliac Occlusive Disease.
Ray JJ; Eidelson SA; Karcutskie CA; Meizoso JP; DeAmorim H; Goldstein LJ; Karwowski J; Bornak A
Ann Vasc Surg; 2018 Jul; 50():73-79. PubMed ID: 29481930
[TBL] [Abstract][Full Text] [Related]
18. Failed superficial femoral artery intervention for advanced infrainguinal occlusive disease has a significant negative impact on limb salvage.
Al-Nouri O; Krezalek M; Hershberger R; Halandras P; Gassman A; Aulivola B; Milner R
J Vasc Surg; 2012 Jul; 56(1):106-10; discussion 110-1. PubMed ID: 22226187
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
20. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
